Norway - Renin-Angiotensin System Medicine Use
Since 2014, Norway Renin-Angiotensin System Medicine Use was up 2% year on year. In 2019, the country was ranked number 17 comparing other countries in Renin-Angiotensin System Medicine Use at 158.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Norway is overtaken by Greece, which was ranked number 16 at 169.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Belgium at 152.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 0.6% versus 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria witnessed the best average annual growth at +10.2% per year, while Chile witnessed the worst performance at -3.5% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 158.60 |
2018 | 151.00 |
2017 | 150.10 |
2016 | 147.50 |
2015 | 145.10 |
How does Norway rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
16 |
#16
Greece
|
170 | 2019 | -1.0 % | +0.1 % | View data | |
17 |
#17
Norway
|
159 | 2019 | +5.0 % | +2.0 % | View data | |
18 |
#18
Belgium
|
153 | 2019 | +2.5 % | +0.2 % | View data |